Media Contact

Blood‑based biomarkers are reshaping Alzheimer’s trials by enabling earlier, cheaper identification. Could these enrolment strategies translate to other slow‑progressing diseases? ICON experts share their insight in the ...

For global clinical trials, localisation, translation availability and linguistic validation can all affect when and how a clinical outcome assessment can be implemented across countries. Yet these considerations are o...

Over 55 million people worldwide live with dementia; Alzheimer’s accounts for 60–80% of cases. ICON is a proud supporter of #WorldAlzheimer’sDay and has participated in 37 clinical studies in Alzheimer's disease and othe...

What if you could cut development timelines by up to 12+ months while reducing costs and operational complexity? At #CPHIMilan, discover how ICON's Manufacturing & Pharmacy Services combine formulation development, GMP m...

We're heading to Boston for The MedTech Conference, 18 – 21 October. Whether you're developing a medical device, diagnostic, digital health technology, wearable, or combination product, successful development requires m...

You can find your best-fit publishing source in as little as five minutes. 5500+ journals and 4400+ congresses with over 50 points of metadata help you make the important decision. PubsHub Journals & Congresses is the f...

Ensuring patient safety lies at the heart of pharmacovigilance, and as global regulations become more rigorous, a proactive and comprehensive safety strategy is essential. At World Patient Safety Congress Europe, visit...

Great teams are built through shared experiences. Our Beijing colleagues recently stepped away from their desks to enjoy a day of team-building activities followed by a group dinner. The event provided a fantastic oppor...

We're looking forward to attending Biomarkers & Precision Medicine 13-14 October in Basel. Discover how ICON's end-to-end precision medicine solutions help sponsors accelerate biomarker-driven development, from biomarke...

ICON is proud to be the Platinum Sponsor of the TOPRA Symposium 2026, Europe’s premier conference for healthcare regulatory affairs. Taking place at the Royal Jaarbeurs in Utrecht from 19 to 21 October, the Symposium wi...

Good governance supports responsible, sustainable business performance. At ICON, ESG oversight is embedded throughout our governance structure extending from the ESG Committee through to the Nominating, Sustainability a...

Eligibility criteria that successfully identify high-risk patients in a clinical trial may be impossible to replicate in routine practice. For MASLD developers, regulatory success and commercial viability are not the sam...